Short‐Course Therapy for Right‐Side Endocarditis Due to Staphylococcus aureus in Drug Abusers: Cloxacillin versus Glycopeptides in Combination with Gentamicin
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
A prospective, randomized clinical trial among drug abusers was conducted to assess the efficacy and safety of a short course of a combination of a glycopeptide (vancomycin or teicoplanin) and gentamicin compared with a combination of cloxacillin and gentamicin for treatment of right-side endocarditis caused by Staphylococcus aureus. Therapeutic success was significantly more frequent with cloxacillin than with a glycopeptide. No adverse effects were noted among patients in the cloxacillin group. A 14-day course of vancomycin or teicoplanin plus gentamicin is ineffective in this instance because it is associated with a high rate of clinical and microbiological failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, in IDUs with uncomplicated right-sided S aureus IE (no evidence of renal failure, extrapulmonary metastatic infections, aortic or mitral valve involvement, meningitis, or infection by MRSA), combined short-course (2 weeks) β-lactam plus aminoglycoside therapy was highly effective in several studies.91,92,148”
In the citing paper
“In contrast, short-course regimens with glycopeptides (teicoplanin or vancomycin) plus gentamicin appeared to be less effective for right-sided S aureus IE caused by either MSSA or MRSA strains.148”
Citations
Cites
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
Clinical Microbiology Procedures Handbook
(2016) · ASM Press eBooks · doi:10.1128/9781555818814 · Cited by 2,240
Levine, D. P., Fromm, B. S., & Reddy, B. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-674 · Cited by 577
Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users
Small, P. M., & Chambers, H. F. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1227 · Cited by 399
Nephrotoxicity of vancomycin, alone and with an aminoglycoside
Rybak, M. J., Albrecht, L. M., Boike, S. C., & Chandrasekar, P. H. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.4.679 · Cited by 388
Chambers, H. F., Miller, R. T., & Newman, M. D. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-8-619 · Cited by 214 · cited 2×
“aureus endocarditis, whereas 47 of 50 patients with methicillin-susceptible isolates were cured with a 2-week course of nafcillin-tobramycin therapy [1].”
BackgroundRibera, E., Gomez-Jimenez, J., Cortes, E., del Valle, O., Planes, A., Gonzalez-Alujas, M. T., Almirante, B., Ocana, I., & Pahissa, A. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-12-199612150-00005 · Cited by 187 · cited 1×
“Moreover, a recent study has confirmed similar results for patients who received 2 weeks of cloxacillin monotherapy, which indicates that adding an aminoglycoside may not be necessary because it does not provide any therapeutic advantage [2].”
ResultGilbert, D. N., Wood, C. A., & Kimbrough, R. C. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.1.79 · Cited by 110
Mild Nephrotoxicity Associated With Vancomycin Use
Downs, N. J. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390080053013 · Cited by 102
Greenberg, R. N. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.12.2392 · Cited by 87
Research works printed but not linked: 2
- Anhalt JP, 1991, DC: American Society for Microbiology, 1192
- Griffin J, 1992, DC: American Society for Microbiology, 5, 17
Cited by
Items 101–124 of 124
Maor, ., & Rubinstein, E. (2006) · Springer eBooks · doi:10.1007/978-1-84628-453-3_3 · Cited by 1
“Fortun [31] confirmed these results by performing a prospective, randomized clinical trial among drug abusers to assess the efficacy and safety of a short course of a combination of a glycopeptide (vancomycin or teicoplanin) and gentamicin compared with a combination of cloxacillin and gentamicin for treatment of righ…”
ResultGlycopeptide Antibacterials and the Treatment of Biofilm-Related Infections
Verna, R., Verhoef, J., & Pace, J. (2005) · CRC Press eBooks · doi:10.1201/9781420028232-27 · Cited by 1
Eguia, J. M., & Chambers, H. F. “. (2005) · Clinical Infectious Diseases · doi:10.1086/444387
Endocarditis infecciosa: el papel de la cirugía
Beneyto, L. A. P., Luis, O. R., & Bayarri, V. M. (2010) · Medicina Clínica · doi:10.1016/j.medcli.2009.10.046 · Cited by 1
Traitement de l'endocardite bactérienne
Thirion, D. J. G., Williamson, D. R., Chaumard, N., Martineau, P., & Ducharme, M. P. (2008) · Elsevier eBooks · doi:10.1016/b978-2-294-06234-6.50053-3
Hyperventilation and Chest Pain in an Adolescent Female: Index of Suspicion
Sawni, A., Wright, K., & Ragothaman, R. (2004) · Clinical Pediatrics · doi:10.1177/000992280404300714
Staphylococcus aureus bacteraemia - Disease progression and prognosis
Forsblom, E. (2014) · Helda - University of Helsinki Institutional Repository
Harder, C. K., & Ensom, M. H. H. (2007) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v60i5.200 · Cited by 1
“als that assessed aminoglycosides in combination with ß-lactams were identified.(27,28) These trials included”
BackgroundMethodEpidemiology, treatment and outcome of Staphylococcus aureus bacteremia and endocarditis
Ruotsalainen, E. A. (2006) · Helda - University of Helsinki Institutional Repository · Cited by 1
Beleslin, B., Deljanin, M., Kanjuh, V., Parapid, B. J., Giga, V. L., Prostran, M. S., Angelkov, L., Balinovac, J., Bikicki, M., Ambrosio, G., et al. (2013)
Staphylococcus aureus: The Persistent Pathogen
Johnston, B., & Conly, J. M. (2003) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2003/274084
“monary metastatic foci, renal insufficiency, pregnancy, leftsided endocarditis and mechanical valves (23,24).”
BackgroundKeynan, Y., & Rubinstein, E. (2016) · Springer eBooks · doi:10.1007/978-3-319-27784-4_3
Vilacosta, I., Blanco, C. O., Cepeda, C. S., Díaz, J. L., Durán, C. F., & Calvar, J. A. S. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-32432-6_15
CLINICAL CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH INFECTIVE ENDOCARDITIS (IE)
Syed, I. (2018) · TSpace (University of Toronto)
(2006) · Elsevier eBooks · doi:10.1016/b0-44-451005-2/00512-x
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.01507-9
Miscellaneous antibacterial drugs
Imhof, A. (2003) · Side effects of drugs annual · doi:10.1016/s0378-6080(03)80033-8
(2010) · Elsevier eBooks · doi:10.1016/b978-0-444-53272-5.50005-4
(2006) · Elsevier eBooks · doi:10.1016/b0-44-451005-2/00505-2
Injection Drug Use-Associated Infective Endocarditis
Barnes, E. W., & Cook, J. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.108171
Combined Antimicrobial Therapy for Infective Endocarditis
Gomez-Villegas, S. I., Miller, W. R., & Arias, C. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-65839-6_16
El-Dalati, S. A., Collis, B., Hall, E., Alnabelsi, T. S., Cao, C. S., Johnson, M., Gurley, J. C., Strnad, L. C., Reda, H. K., Sekela, M. E., et al. (2025) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaf171
2025 Clinical practice guidelines for Infectious endocarditis and infection of intracardiac devices
Кобалава, Ж. Д., Демин, А. А., Titov, D. A., Kozlov, R. S., Artyukhina, Е. А., Boytsov, S. A., Golukhova, E. Z., Гордеев, М. Л., Gudymovich, V. D., А., Д. Е., et al. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2026-6853 · Cited by 1
Managing infective endocarditis among people who inject drugs: Challenges and emerging solutions
Keynan, Y., Riaño, W., Laupland, K., Lother, S., & Rueda, Z. V. (2026) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi-2026-0921
Metadata
- Authors
- Fortún, J., Navas, E., Martínez‐Beltrán, J., Pérez‐Molina, J., Martín‐Dávila, P., Guerrero, A., & Moreno, S.
- Affiliations
- Hospital Universitario Ramón y Cajal (ES)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-07
- Volume
- 33
- Issue
- 1
- Pages
- 120-125
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2144592242
- Semantic Scholar
- f5a3d69c04b44df6f88c0ed011b8287037b67ff4
- Cited by
- 126
- References
- 24
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2022: 2 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 5 · 2016: 3 · 2015: 7 · 2014: 4 · 2013: 3 · 2012: 4
- FWCI
- 4.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Keywords
- right-sided endocarditis, Staphylococcus aureus, drug abusers, short-course antibiotic therapy, cloxacillin, vancomycin, teicoplanin, gentamicin, glycopeptides, combination antibiotic therapy, treatment failure
- MeSH terms
- Adolescent, Adult, Anti-Bacterial Agents, Cloxacillin, Drug Therapy, Combination, Endocarditis, Bacterial, Female, Gentamicins, Glycopeptides, Humans, Male, Prospective Studies, Staphylococcal Infections, Staphylococcus aureus, Substance Abuse, Intravenous, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.